Yao-Chung Chiang Biography and Net Worth

Director of Ainos


Mr. Chiang has served as a Director of the Company since April 2021 and has served as a member of our Audit Committee since August 2021. Mr. Chiang served as the chairman of Taiwan High Speed Rail Corporation from October 2016 to January 2025, and has served as an independent director of Golden Friends Corp. since June 2025 and as an independent director for Radiant Opto-Electronics Corporation since June 2012. From June 2015 to July 2021, Mr. Chang was an independent director for Tyntek Corp. Mr. Chiang served as the chairman for other Taiwan-incorporated companies including China Steel Chemical Corporation, Kaohsiung Rapid Transit Corporation, China Steel Corporation and China Airlines. Mr. Chiang holds a Ph.D. in Mechanical Engineering from University of Wisconsin-Madison.

What is Yao-Chung Chiang's net worth?

The estimated net worth of Yao-Chung Chiang is at least $14.55 thousand as of June 5th, 2026. Mr. Chiang owns 11,279 shares of Ainos stock worth more than $14,550 as of October 7th. This net worth evaluation does not reflect any other investments that Mr. Chiang may own. Learn More about Yao-Chung Chiang's net worth.

How do I contact Yao-Chung Chiang?

The corporate mailing address for Mr. Chiang and other Ainos executives is 3050 Post Oak Blvd,, Suite 510-t80, Houston, TX, 77056. Ainos can also be reached via phone at (281) 898-6586 and via email at [email protected]. Learn More on Yao-Chung Chiang's contact information.

Has Yao-Chung Chiang been buying or selling shares of Ainos?

Yao-Chung Chiang has not been actively trading shares of Ainos over the course of the past ninety days. Most recently, on Friday, June 5th, Yao-Chung Chiang bought 3,500 shares of Ainos stock. The stock was acquired at an average cost of $2.05 per share, with a total value of $7,175.00. Following the completion of the transaction, the director now directly owns 11,279 shares of the company's stock, valued at $23,121.95. Learn More on Yao-Chung Chiang's trading history.

Who are Ainos' active insiders?

Ainos' insider roster includes Yao-Chung Chiang (Director), Ting-Chuan Lee (Director), and Chun-Jung Tsai (Director). Learn More on Ainos' active insiders.

Are insiders buying or selling shares of Ainos?

During the last year, Ainos insiders bought shares 5 times. They purchased a total of 7,800 shares worth more than $15,946.00. During the last year, insiders at the sold shares 7 times. They sold a total of 227,069 shares worth more than $461,398.62. The most recent insider tranaction occured on June, 5th when Director Yao-Chung Chiang bought 3,500 shares worth more than $7,175.00. Insiders at Ainos own 9.8% of the company. Learn More about insider trades at Ainos.

Information on this page was last updated on 6/5/2026.

Yao-Chung Chiang Insider Trading History at Ainos

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/5/2026Buy3,500$2.05$7,175.0011,279View SEC Filing Icon  
6/3/2026Buy2,000$2.13$4,260.007,779View SEC Filing Icon  
5/27/2026Buy2,000$2.00$4,000.005,529View SEC Filing Icon  
4/30/2026Buy200$1.68$336.00700View SEC Filing Icon  
4/29/2026Buy100$1.75$175.00500View SEC Filing Icon  
See Full Table

Yao-Chung Chiang Buying and Selling Activity at Ainos

This chart shows Yao-Chung Chiang's buying and selling at Ainos by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ainos Company Overview

Ainos logo
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
Read More

Today's Range

Now: $1.24
Low: $1.23
High: $1.28

50 Day Range

MA: $1.42
Low: $1.24
High: $1.60

2 Week Range

Now: $1.24
Low: $1.20
High: $4.44

Volume

16,521 shs

Average Volume

387,915 shs

Market Capitalization

$9.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.47